Navigation Links
Hadasit Bio-Holdings CEO Letter to Shareholders
Date:4/9/2013

s conditionally based on initially investing a relatively small amount of capital in order to finance a feasibility trial with one of Hadassah's specialists, while having the option of investing significantly after the initial trial if successful. We are also looking into the possibility of diversifying our portfolio by adding companies that develop  products which require less regulation and present a shorter time to market, such as medical devices and medical IT – fields in which Hadassah is already an established world leader.

In summary, we feel that our maturing portfolio, unique list of valuable assets, proven expertise in numerous fields of science, and experienced and hands-on management, coupled with an attractive share price and substantial growth potential for the Israeli biotechnology industry – all make HBL a highly attractive investment opportunity. Furthermore, the fact that an investment in the Company would directly help progress the research and development of innovative medical treatments with the potential to save thousands or even millions of lives from all over the world make it not only rewarding financially, but important in many other ways.

We remain confident in our assertion that 2013 promises to be a noteworthy year for HBL and its investors. We are immensely proud to have your confidence as shareholders, potential investors and partners for success. Your continued support and involvement only validates and affirms our corporate mission; to not only be a success financially, but to succeed in providing innovative medical treatments for the betterment of mankind.

About Hadasit Bio-Holdings

Hadasit Bio-Holdings, Ltd., established in 2006, is the publicly traded subsidiary of Hadasit Ltd. - the technology transfer company of the Hadassah University Hospital, Israel's foremost medical research center. The Company was established for the purpose of promoting and commercial
'/>"/>

SOURCE Hadasit Bio-Holdings Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
2. KAHR Medical, a Hadasit Bio-Holdings Portfolio Company, to Raise $2.6 Million
3. Hadasit Bio-Holdings Interviewed by Wall Street Reporter
4. Hadasit Bio-Holdings Ltd. Portfolio Companies - ProtAb Ltd. and KAHR Medical Ltd. to Receive NIS 10.7 Million (Over $2.8 Million USD) in Additional Government Grants
5. NeoStems CEO Letter to Shareholders
6. Genesis Biopharma Issues Letter To Shareholders
7. Bacterin Receives Letter From NYSE MKT LLC Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders
8. Elsevier to Participate in SCOAP3 With the Journals Physics Letters B and Nuclear Physics B
9. Ronald L. Chez Files Amended 13D and Letter to the Board
10. Mangrove Partners Sends Letter to Stockholders of Nabi Biopharmaceuticals
11. Amarantus BioSciences Issues CEO Letter to Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015  Peter Walter was chosen as winner ... pioneering work on how proteins are transported between cellular ... mechanism that cells use to handle stress tied to ... professor of biochemistry at the University of California, San ... range of human diseases related to defective protein folding ...
(Date:3/27/2015)... , March 27, 2015  CASI Pharmaceuticals, Inc. ... the acquisition, development and commercialization of innovative therapeutics addressing ... market with a commercial focus on China ... and 12 months ended December 31, 2014.  ... million), or ($0.05) per share, for the three months ...
(Date:3/26/2015)... March 26, 2015 PRC Clinical, a ... today several management and executive appointments effective immediately. , ... Officer (CFO) and member of the Board of Directors. ... Operations, and Sue Dowden will assume the position of ... current Chief Operations Officer (COO), has been appointed to ...
(Date:3/26/2015)... , March 26, 2015  BioNano Genomics, Inc., ... of  Terry Salyer as chief commercial officer. Salyer ... effective, worldwide sales teams in life sciences. At BioNano, ... System, a genome-mapping platform to assemble a comprehensive ... structural variations. To date, 32 institutions located in ...
Breaking Biology Technology:German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 2German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 2PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 3BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 2BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 3
... DIEGO, June 15 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ... previously announced sale of shares of convertible preferred stock pursuant ... representing gross proceeds of approximately $2 million. The preferred stock ... option of the investor at a price of $0.1105 per ...
... Inc., an award-winning developer of Microfluidics and Live ... its cellTRAY Imaging System and cellTRAY Fluidics System ... Imaging and Fluidics Systems provide solutions to a ... reproductive technology (ART), stem cell research, and cryobiology, ...
... to be made on June 26, 2009 , , SEATTLE, ... announced today that it has been included on a list of ... posted by Russell Investments on June 12, 2009 on ... U.S. and global equity indexes on June 26, 2009. , ...
Cached Biology Technology:ADVENTRX Pharmaceuticals Announces Closing of Financing 2ADVENTRX Pharmaceuticals Announces Closing of Financing 3Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems 2Cell Therapeutics on Preliminary List of Additions to Russell 3000(R) Index and Russell Global(R) Index 2Cell Therapeutics on Preliminary List of Additions to Russell 3000(R) Index and Russell Global(R) Index 3
(Date:3/24/2015)... Fla. , March 24, 2015   ... management solutions, today announced that its U.are.U ® ... accessory retailer Goorin Bros . to achieve ... biometrics-based solution secures access to the POS terminal, ... increased risk of data breaches. ...
(Date:3/23/2015)... , Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, announces its biometric ... advertising campaign on CNBC television starting March 30 th ... commence airing in New York markets. ... said: "We are excited about our new ad campaign following ...
(Date:3/20/2015)... Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has ... Strategic Business Report" report to their offering. ... US$ Thousands. The report provides separate comprehensive analytics for the ... , Europe , Asia-Pacific ... Latin America . Annual estimates and forecasts ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
... Mosbach, Germany, April 2, 2012 Biochemist and geneticist Alexander ... Moscow and has lived in the USA since 1977, has ... for Biochemistry and Molecular Biology (GBM). That medal is considered ... biologists. By means of genetic research carried out ...
... Bethesda, MD -- A new discovery in mice may lead ... likely to succeed and to be significantly less dangerous. According ... Leukocyte Biology ( https://www.jleukbio.org ) Brazilian scientists may have ... transplant grafts and damaging the host,s own cells after a ...
... most vibrant and celebrated works, Vincent van Gogh,s series of ... until now, been a bit of a mystery. ... PLoS Genetics , however, a team of University of ... of yellow "double flowers" that the post-Impressionist artist painted more ...
Cached Biology News:Otto Warburg Medal for Alexander Varshavsky 2Otto Warburg Medal for Alexander Varshavsky 3New discovery may lead to effective prevention and treatment of graft-versus-host dsease 2UGA scientists reveal genetic mutation depicted in van Gogh's sunflower paintings 2
... ion trap mass spectrometer enables high-throughput solutions ... LXQ linear ion trap mass spectrometer is ... delivering the fast cycle time and increased ... at an attractive price. The combination ...
... DNA gel stain was developed specifically for reduced ... for staining DNA in agarose or acrylamide gels. ... than ethidium bromide but SYBR Safe stain's detection ... SYBR Safe stain comes as a premixed solution ...
... some the things youll be telling others after ... by Erica Golemis, One look at the table ... topics in protein interaction will tell you immediately ... a part of your personal protein chemistry library. ...
... gel stain has bright fluorescence when bound to ... ideal for detecting dsDNA in gels using laser ... I nucleic gel acid stain has also ... and bandshift assays. One mL stains 100 minigels. ...
Biology Products: